190 related articles for article (PubMed ID: 15925706)
21. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene.
Kreek MJ; LaForge KS
Mol Interv; 2007 Apr; 7(2):74-8. PubMed ID: 17468387
[TBL] [Abstract][Full Text] [Related]
22. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
[TBL] [Abstract][Full Text] [Related]
23. Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity.
Han W; Kasai S; Hata H; Takahashi T; Takamatsu Y; Yamamoto H; Uhl GR; Sora I; Ikeda K
Pharmacogenet Genomics; 2006 Jun; 16(6):451-60. PubMed ID: 16708053
[TBL] [Abstract][Full Text] [Related]
24. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses.
Uhl GR; Sora I; Wang Z
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7752-5. PubMed ID: 10393893
[TBL] [Abstract][Full Text] [Related]
25. Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene,
Liu S; Kang WJ; Abrimian A; Xu J; Cartegni L; Majumdar S; Hesketh P; Bekker A; Pan YX
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680158
[TBL] [Abstract][Full Text] [Related]
26. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
Stimmel B; Kreek MJ
Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
[TBL] [Abstract][Full Text] [Related]
27. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
Woolf CJ; Hashmi M
Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
[TBL] [Abstract][Full Text] [Related]
28. Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1).
Kranzler HR; Gelernter J; O'Malley S; Hernandez-Avila CA; Kaufman D
Alcohol Clin Exp Res; 1998 Sep; 22(6):1359-62. PubMed ID: 9756053
[TBL] [Abstract][Full Text] [Related]
29. Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.
Rhodin A; Grönbladh A; Ginya H; Nilsson KW; Rosenblad A; Zhou Q; Enlund M; Hallberg M; Gordh T; Nyberg F
Mol Brain; 2013 Feb; 6():8. PubMed ID: 23402298
[TBL] [Abstract][Full Text] [Related]
30. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.
Huang CJ; Liu HF; Su NY; Hsu YW; Yang CH; Chen CC; Tsai PS
Anaesthesia; 2008 Dec; 63(12):1288-95. PubMed ID: 19032295
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms and human sensitivity to opioid analgesics.
Nishizawa D; Hayashida M; Nagashima M; Koga H; Ikeda K
Methods Mol Biol; 2010; 617():395-420. PubMed ID: 20336437
[TBL] [Abstract][Full Text] [Related]
32. [Functional selectivity of opioid receptors ligands].
Audet N; Archer-Lahlou E; Richard-Lalonde M; Piñeyro-Filpo G
Med Sci (Paris); 2010; 26(8-9):734-9. PubMed ID: 20819711
[TBL] [Abstract][Full Text] [Related]
33. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
34. Genetics of pain, opioids, and opioid responsiveness.
Tremblay J; Hamet P
Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of opioid pharmacogenetics.
Argoff CE
Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of OPRM1.
Crist RC; Berrettini WH
Pharmacol Biochem Behav; 2014 Aug; 123():25-33. PubMed ID: 24201053
[TBL] [Abstract][Full Text] [Related]
37. Understanding the genetic determinants of pain and pain management.
Miaskowski C
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
[TBL] [Abstract][Full Text] [Related]
38. The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes.
Zwisler ST; Enggaard TP; Noehr-Jensen L; Mikkelsen S; Verstuyft C; Becquemont L; Sindrup SH; Brosen K
Fundam Clin Pharmacol; 2010 Aug; 24(4):517-24. PubMed ID: 19845769
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment.
Walter C; Lötsch J
Pain; 2009 Dec; 146(3):270-275. PubMed ID: 19683391
[TBL] [Abstract][Full Text] [Related]
40. Expansion of the human mu-opioid receptor gene architecture: novel functional variants.
Shabalina SA; Zaykin DV; Gris P; Ogurtsov AY; Gauthier J; Shibata K; Tchivileva IE; Belfer I; Mishra B; Kiselycznyk C; Wallace MR; Staud R; Spiridonov NA; Max MB; Goldman D; Fillingim RB; Maixner W; Diatchenko L
Hum Mol Genet; 2009 Mar; 18(6):1037-51. PubMed ID: 19103668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
